T2	eligibility 512 548	women with stage I-III breast cancer
T3	total-participants 786 790	6018
T4	outcome 801 816	developed BRONJ
T5	outcome 818 827	Infection
T6	outcome 855 875	Median time to BRONJ
T7	outcome 957 962	BRONJ
T8	iv-bin-abs 1004 1006	28
T9	intervention-participants 1007 1011	2231
T10	iv-bin-percent 1013 1018	1.26%
T15	iv-bin-abs 1028 1029	8
T16	intervention-participants 1030 1034	2235
T17	iv-bin-percent 1036 1041	0.36%
T18	iv-bin-abs 1051 1053	12
T19	intervention-participants 1054 1058	1552
T20	iv-bin-percent 1060 1065	0.77%
T21	outcome 1234 1262	BRONJ occurred spontaneously
T22	iv-cont-median 898 907	2.0 years
T23	iv-cont-median 920 929	3.4 years
T24	outcome 1076 1091	dental calculus
T27	outcome 1103 1113	gingivitis
T28	outcome 1125 1160	moderate/severe periodontal disease
T29	outcome 1176 1196	periodontitis > 4 mm
T11	condition 43 67	osteonecrosis of the jaw
T13	outcome 1297 1314	dental extraction
T14	outcome 1330 1349	periodontal disease
T25	outcome 1365 1379	denture trauma
T26	outcome 1398 1412	dental surgery
T30	outcome 1426 1443	Spontaneous BRONJ
T1	intervention 107 131	adjuvant bisphosphonates
